Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp., trading under the ticker SRSA, is a blank-check company sponsored by Sarissa Capital Management, the activist healthcare investment firm led by Alex Denner. The SPAC went public in 2020, targeting acquisition opportunities in the biopharmaceutical and healthcare sectors — areas where the sponsor has a long track record of concentrated, high-conviction investing. An S-1/A amendment was filed with the SEC on October 9, 2020, under accession number 0001193125-20-267333, reflecting standard pre-IPO disclosure updates. The vehicle was structured to leverage Sarissa's deep sector relationships and scientific advisory network in sourcing a combination target. Sign up for a SpacDesk account to access full filing history, timeline data, and deal analytics for SRSA and hundreds of other SPACs.